Genetic Analysis AS (NGM:GEAN)

Sweden flag Sweden · Delayed Price · Currency is SEK · Price in NOK
0.9000
+0.0200 (2.27%)
At close: Jul 1, 2025
32.35%
Market Cap 57.22M
Revenue (ttm) 19.01M
Net Income (ttm) -12.93M
Shares Out 69.09M
EPS (ttm) -0.28
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 149,041
Average Volume 65,259
Open 0.9000
Previous Close 0.8800
Day's Range 0.8700 - 0.9200
52-Week Range 0.3100 - 2.6000
Beta 2.42
RSI 44.33
Earnings Date Aug 29, 2025

About Genetic Analysis AS

Genetic Analysis AS, a science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally. It offers GA-map, a platform for the analysis of the human gut microbiota; GA-map Dysbiosis Test that detects and characterizes dysbiosis; and GA-map Analyzer, a cloud-based software solution. The company also provides GA-map Discovery, a tool to search biomarkers and validate research findings or transfer the findings to a ready-to-use routine testing platform; GA-map Sample Colle... [Read more]

Sector Healthcare
Founded 2008
Employees 16
Stock Exchange Nordic Growth Market
Ticker Symbol GEAN
Full Company Profile

Financial Performance

In 2024, Genetic Analysis AS's revenue was 20.68 million, a decrease of -10.71% compared to the previous year's 23.16 million. Losses were -14.77 million, -37.99% less than in 2023.

Financial numbers in NOK Financial Statements

News

There is no news available yet.